You are here: Industry Insights > Amgen

News List

Amgen, UCB Receives Negative Opinion on EMA Application EVENITY™ in EU americanpharmaceuticalreview
July 01, 2019
Amgen and UCB announced the companies have been informed the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion on ...
Amgen and University of Washington partner on biotech drug discovery pharmaceutical-technology
June 21, 2019
Amgen has signed a strategic research partnership with the University of Washington’s Institute for Protein Design (IPD) that will apply IPD’s de novo protein design expertise to biotech drug discovery.
Amgen and IPD Partner for Drug Research contractpharma
June 21, 2019
Covering multiple projects, testing new technologies, and creating protein-building approaches for new medicines.
FDA approves Amgen and Allergan's KANJINTITM (trastuzumab-anns), a biosimilar to Herceptin® (trastuzumab) worldpharmanews
June 20, 2019
FDA approves Amgen and Allergan's KANJINTITM (trastuzumab-anns), a biosimilar to Herceptin® (trastuzumab).
Amgen and Allergan secure US FDA approval for Herceptin biosimilar pharmaceutical-technology
June 19, 2019
The US Food and Drug Administration (FDA) has approved Amgen and Allergan’s Kanjinti (trastuzumab-anns).
Amgen connects Chicago artists, social media voices in BiTE marketing push fiercepharma
June 12, 2019
Amgen tapped Chicago street artists Shaun Hays and Nate Baranowski to create 3D chalk artwork near the Field Museum and Shedd Aquarium—and at Amgen's booth onsite at ASCO—for several days during the meeting.
Amgen joins with community oncology networks for new research collaboration worldpharmanews
May 29, 2019
Amgen (NASDAQ: AMGN), along with leading community oncology networks, today announced the launch of Amgen Community Oncology Research Collaborators (ACORC), a new initiative to enhance access by community centers to innovative oncology clinical research.
Mass exodus of Amgen sales reps sparks legal battle with multiple myeloma rival Karyopharm biospectrumasia
May 29, 2019
What’s a pharma company to do when another drugmaker poaches 19 of its salespeople in preparation for launching a rival product?
Amgen offers $167m to acquire Nuevolution pharmaceutical-technology
May 24, 2019
Amgen has made a public offer to buy Denmark-based biopharmaceutical company Nuevolution for a cash consideration of around $167m.
Amgen, Syapse Enter Precision Medicine Pact contractpharma
May 16, 2019
To develop observational research analytics to assess treatment outcomes for areas of unmet need in oncology.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 22 23 Next page